These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 9576366)
1. Intraperitoneal pulse calcitriol in the treatment of secondary hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis. Chan HW; Tsang WK; Chan CM; Fung SK; So SO; Tang HL; Tong MK; Lee KC; Chan AY Perit Dial Int; 1998; 18(2):177-82. PubMed ID: 9576366 [TBL] [Abstract][Full Text] [Related]
2. Oral paricalcitol versus oral calcitriol in continuous ambulatory peritoneal dialysis patients with secondary hyperparathyroidism. Jamaluddin EJ; Gafor AH; Yean LC; Cader R; Mohd R; Kong NC; Shah SA Clin Exp Nephrol; 2014 Jun; 18(3):507-14. PubMed ID: 23903802 [TBL] [Abstract][Full Text] [Related]
3. Pulse oral calcitriol for the treatment of hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis: preliminary observations. Martin KJ; Ballal HS; Domoto DT; Blalock S; Weindel M Am J Kidney Dis; 1992 Jun; 19(6):540-5. PubMed ID: 1595702 [TBL] [Abstract][Full Text] [Related]
4. Calcium kinetic studies in patients on CAPD: improvement of secondary hyperparathyroidism without concomitant improvement of calcium turnover. Kurz P; Tsobanelis T; Brunkhorst R; Roth P; Werner E; Schoeppe W; Vlachojannis J Perit Dial Int; 1997; 17(1):59-65. PubMed ID: 9068024 [TBL] [Abstract][Full Text] [Related]
5. Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Collaborators of the Multicenter Study Group. Weinreich T; Ritz E; Passlick-Deetjen J Perit Dial Int; 1996; 16(3):260-8. PubMed ID: 8761540 [TBL] [Abstract][Full Text] [Related]
6. Suppression of parathyroid hormone secretion in CAPD patients by intraperitoneal administration of Maxacalcitol. Murakami K; Miyachi H; Watanabe A; Kawamura N; Fujii M; Koide S; Murase M; Kushimoto H; Hasegawa M; Tomita M; Hiki Y; Sugiyama S Clin Exp Nephrol; 2004 Jun; 8(2):134-8. PubMed ID: 15235930 [TBL] [Abstract][Full Text] [Related]
8. Paricalcitol in dialysis patients with calcitriol-resistant secondary hyperparathyroidism. Llach F; Yudd M Am J Kidney Dis; 2001 Nov; 38(5 Suppl 5):S45-50. PubMed ID: 11689387 [TBL] [Abstract][Full Text] [Related]
9. Limitations of pulse oral calcitriol therapy in continuous ambulatory peritoneal dialysis patients. Bechtel U; Mücke C; Feucht HE; Schiffl H; Sitter T; Held E Am J Kidney Dis; 1995 Feb; 25(2):291-6. PubMed ID: 7847357 [TBL] [Abstract][Full Text] [Related]
10. Long-term effect of oral calcitriol single weekly pulse in CAPD and in HD. Romanini D; Gazo A; Bellazzi R; de Vincenzi A; Nai M; Santagostino M Adv Perit Dial; 1994; 10():267-9. PubMed ID: 7999842 [TBL] [Abstract][Full Text] [Related]
11. Pulse oral calcitriol to treat hyperparathyroidism in 43 CAPD patients. Juergensen P; Santacroce S; Mooraki A; Cooper K; Finkelstein FO; Kliger AS Adv Perit Dial; 1994; 10():259-60. PubMed ID: 7999840 [TBL] [Abstract][Full Text] [Related]
12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
13. Hyperparathyroidism in CAPD patients: therapy with pulse oral calcitriol. Juergensen PH; Finkelstein FO; Cooper K; Santacroce S; Kliger AS Adv Perit Dial; 1993; 9():257-9. PubMed ID: 8105938 [TBL] [Abstract][Full Text] [Related]
14. Long-term effects of intravenous calcitriol therapy on the control of secondary hyperparathyroidism. Malberti F; Corradi B; Cosci P; Calliada F; Marcelli D; Imbasciati E Am J Kidney Dis; 1996 Nov; 28(5):704-12. PubMed ID: 9158208 [TBL] [Abstract][Full Text] [Related]
15. Effect of CAPD and hemodialysis on parathyroid function. Malberti F; Corradi B; Imbasciati E Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912 [TBL] [Abstract][Full Text] [Related]
16. Effects of subcutaneous calcitriol administration on plasma calcium and parathyroid hormone concentrations in continuous ambulatory peritoneal dialysis uremic patients. Rolla D; Paoletti E; Marsano L; Mulas D; Peloso G; Cannella G Perit Dial Int; 1993; 13(2):118-21. PubMed ID: 8494932 [TBL] [Abstract][Full Text] [Related]